Arrowstreet Capital’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $13M | Sell |
|
|||||
|
2025
Q2 | $13.7M | Sell |
|
|||||
|
2025
Q1 | $15M | Buy |
|
|||||
|
2024
Q4 | $12.2M | Sell |
|
|||||
|
2024
Q3 | $17.2M | Buy |
|
|||||
|
2024
Q2 | $5.08M | Buy |
|
|||||
|
2024
Q1 | $3.83M | Buy |
|
|||||
|
2023
Q4 | $1.28M | Sell |
|
|||||
|
2023
Q3 | $3.39M | Sell |
|
|||||
|
2023
Q2 | $2.83M | Buy |
|
|||||
|
2023
Q1 | $947K | Buy |
|
|||||
|
2022
Q4 | $990K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $1.46M | Buy |
|
|||||
|
2021
Q4 | $970K | Buy |
|
|||||
|
2021
Q3 | $487K | Sell |
|
|||||
|
2021
Q2 | $1.28M | Sell |
|
|||||
|
2021
Q1 | $3.44M | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $443K | Sell |
|
|||||
|
2020
Q2 | $6.14M | Buy |
|
|||||
|
2020
Q1 | $693K | Buy |
|
|||||
|
2019
Q4 | $934K | Buy |
|